Disclosed herein are methods for modifying a substrate having a hydrophobic surface. Also disclosed are modified hydrophobic substrates. The modified hydrophobic substrates and methods disclosed herein advantageously improve cell affinity and antithrombogenicity of hydrophobic surfaces.

A powder coating composition can include: a polyester polymer having carboxylic acid functional groups; a first crosslinker reactive with the carboxylic acid functional groups of the polyester polymer; and a fluoropolymer unreactive with the polyester polymer and first crosslinker. A weight ratio of the polyester polymer to the fluoropolymer is from 80:20 to 60:40. When cured, the powder coating composition forms a single coating layer including the polyester polymer and the fluoropolymer.

A powder coating composition can include: a polyester polymer having carboxylic acid functional groups; a first crosslinker reactive with the carboxylic acid functional groups of the polyester polymer; and a fluoropolymer unreactive with the polyester polymer and first crosslinker. A weight ratio of the polyester polymer to the fluoropolymer is from 80:20 to 60:40. When cured, the powder coating composition forms a single coating layer including the polyester polymer and the fluoropolymer.

In various aspects, the disclosure relates to polycarbonate compositions exhibiting improved impact strength, both multi axial and notched Izod, as well as thin-walled flame resistance while free or substantially free of bromine or chlorine flame retardant additives. The polycarbonate compositions may comprise non-bonding glass fiber, butyl tosylate, and/or a phosphorous based stabilizer.

In various aspects, the disclosure relates to polycarbonate compositions exhibiting improved impact strength, both multi axial and notched Izod, as well as thin-walled flame resistance while free or substantially free of bromine or chlorine flame retardant additives. The polycarbonate compositions may comprise non-bonding glass fiber, butyl tosylate, and/or a phosphorous based stabilizer.

In an embodiment, a method of producing a radiopaque stent graft is provided. The method may include functionalizing a surface of a coating layer of a stent graft to produce a functionalized surface; disposing a tie layer over the functionalized exterior surface of the stent graft; disposing an adherent layer over the tie layer; etching a slot into the adherent layer; functionalizing the slot; and positioning a radiopaque marker in the slot to produce a filled slot and thereby produce the radiopaque stent graft.

In an embodiment, a method of producing a radiopaque stent graft is provided. The method may include functionalizing a surface of a coating layer of a stent graft to produce a functionalized surface; disposing a tie layer over the functionalized exterior surface of the stent graft; disposing an adherent layer over the tie layer; etching a slot into the adherent layer; functionalizing the slot; and positioning a radiopaque marker in the slot to produce a filled slot and thereby produce the radiopaque stent graft.

In an embodiment, a method of producing a radiopaque stent graft is provided. The method may include functionalizing a surface of a coating layer of a stent graft to produce a functionalized surface; disposing a tie layer over the functionalized exterior surface of the stent graft; disposing an adherent layer over the tie layer; etching a slot into the adherent layer; functionalizing the slot; and positioning a radiopaque marker in the slot to produce a filled slot and thereby produce the radiopaque stent graft.

To reinforce a layer that is configured to contain fluororesin while suppressing the thickness of the entire medical tube. A medical tube includes a first resin layer that is configured to contain fluororesin, and a second resin layer that is configured to coat an outer peripheral surface of the first resin layer and containing polyimide resin. The thickness of the second resin layer is larger than 0 μm but not exceeding 15 μm.

To reinforce a layer that is configured to contain fluororesin while suppressing the thickness of the entire medical tube. A medical tube includes a first resin layer that is configured to contain fluororesin, and a second resin layer that is configured to coat an outer peripheral surface of the first resin layer and containing polyimide resin. The thickness of the second resin layer is larger than 0 μm but not exceeding 15 μm.